Turmeric’s cancer preventive properties: Sharda University inks research pact with pharma company

NEW DELHI, MAY 8: The School of Dental Sciences, Sharda University has signed an agreement with a nutri-pharmaceutical company, Oncocur India, to conduct research on properties of turmeric to combat oral cancer minus side effects.

Nano-Curcumin, a component of turmeric could hold the key to preventing the progression of abrasions that lead to oral cancer. The current treatment for commonly found oral lesions or white patches in the mouth consists of medications that have serious side effects, whereas the proposed treatment uses nano-curcumin derived out of turmeric to resolve abrasions. Nano-curcumin is well tolerated by the body and has next to no side effects. It is expected to cure tobacco and stress-induced white patches in the mouth along with ulcers that persist even after treatment.

“The research will aid better, faster and effective cancer and pre-cancer diagnosis, care and management. As part of the studies conducted by the department on oral pre-cancer, the research is a great step towards delivering cutting edge treatment to cure cancer in the preliminary stages,” said Dr. Deepak Bhargava, Professor and Head of Department of Oral Pathology at Sharda University.

Oncocur, an emerging nano medicine company with a focus on next generation nano particles-based precision therapeutics for oncology, has granted Rs. 6 lakhs for the research project. The research will be undertaken by the Department of Oral Pathology, School of Dental Sciences.